inhaled insulin

MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It

MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It

TheStreet.com

MannKind's Afrezza Likely To Easily Gain Approval

MannKind's Afrezza Likely To Easily Gain Approval

Seeking Alpha

MannKind's Afrezza Likely To Fail AFFINITY 1 Phase III Trial

MannKind's Afrezza Likely To Fail AFFINITY 1 Phase III Trial

Seeking Alpha

Long MannKind's Afrezza: Shares Versus A Bull Call Spread

Long MannKind's Afrezza: Shares Versus A Bull Call Spread

Seeking Alpha

3 Reasons Pfizer Should Partner With MannKind

3 Reasons Pfizer Should Partner With MannKind

Motley Fool

MannKind Fights On With Its Diabetes Game-Changer Afrezza

MannKind Fights On With Its Diabetes Game-Changer Afrezza

Seeking Alpha

MannKind: Will The Good News Ever Come?

MannKind: Will The Good News Ever Come?

Seeking Alpha

MannKind Corp. Investors Like What They See

MannKind Corp. Investors Like What They See

Seeking Alpha

Risk-Reward Balanced at MannKind

Risk-Reward Balanced at MannKind

Yahoo/Zacks.com

MannKind gets clear path forward for inhaled insulin

MannKind gets clear path forward for inhaled insulin

Pharma Times, UK